Longboard Pharmaceuticals Inc (LBPH)
21.38
-1.44
(-6.29%)
USD |
NASDAQ |
May 03, 16:00
21.37
0.00 (0.00%)
After-Hours: 20:00
Longboard Pharmaceuticals Market Cap: 769.87M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 769.87M |
| May 02, 2024 | 821.55M |
| May 01, 2024 | 790.94M |
| April 30, 2024 | 767.17M |
| April 29, 2024 | 764.65M |
| April 26, 2024 | 710.26M |
| April 25, 2024 | 693.33M |
| April 24, 2024 | 711.34M |
| April 23, 2024 | 730.07M |
| April 22, 2024 | 672.44M |
| April 19, 2024 | 628.14M |
| April 18, 2024 | 648.67M |
| April 17, 2024 | 612.29M |
| April 16, 2024 | 657.31M |
| April 15, 2024 | 657.31M |
| April 12, 2024 | 691.53M |
| April 11, 2024 | 736.55M |
| April 10, 2024 | 659.47M |
| April 09, 2024 | 669.20M |
| April 08, 2024 | 654.79M |
| April 05, 2024 | 649.75M |
| April 04, 2024 | 665.96M |
| April 03, 2024 | 652.63M |
| April 02, 2024 | 712.42M |
| April 01, 2024 | 758.16M |
| Date | Value |
|---|---|
| March 28, 2024 | 777.97M |
| March 27, 2024 | 755.64M |
| March 26, 2024 | 724.31M |
| March 25, 2024 | 714.58M |
| March 22, 2024 | 719.62M |
| March 21, 2024 | 719.26M |
| March 20, 2024 | 740.51M |
| March 19, 2024 | 741.95M |
| March 18, 2024 | 737.63M |
| March 15, 2024 | 695.85M |
| March 14, 2024 | 680.36M |
| March 13, 2024 | 718.90M |
| March 12, 2024 | 684.33M |
| March 11, 2024 | 708.10M |
| March 08, 2024 | 708.10M |
| March 07, 2024 | 722.70M |
| March 06, 2024 | 713.51M |
| March 05, 2024 | 723.05M |
| March 04, 2024 | 759.12M |
| March 01, 2024 | 754.52M |
| February 29, 2024 | 784.22M |
| February 28, 2024 | 846.45M |
| February 27, 2024 | 827.36M |
| February 26, 2024 | 812.51M |
| February 23, 2024 | 794.48M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
50.61M
Minimum
Jul 01 2022
921.41M
Maximum
Jan 23 2024
186.60M
Average
123.41M
Median
Market Cap Benchmarks
| CEL-SCI Corp | 87.99M |
| AIM ImmunoTech Inc | 20.20M |
| IGC Pharma Inc | 32.58M |
| NovaBay Pharmaceuticals Inc | 2.856M |
| Protalix BioTherapeutics Inc | 83.28M |
Market Cap Related Metrics
| Price to Book Value | 18.81 |
| Price | 21.38 |
| Earnings Yield | -11.14% |